Division of Molecular Oncology, Institute of Cytology & Preventive Oncology (ICMR), Noida, India.
Indian J Med Res. 2009 Sep;130(3):222-33.
Clinico-epidemiological and molecular studies have established the casual link between Human Papillomavirus (HPV) infection and cervical cancer as also association of HPV infection with several other cancers. In India, cervical cancer is a leading cancer among women and almost all cases of cervical cancer show prevalence of High Risk (HR)-HPV infection. HPV has been also detected in a significant proportion of oral, esophageal, anal, vaginal, vulvar, and penile cancer and in a small percentage of lung, laryngeal, and stomach cancer in India. Due to lack of organized HPV screening program, insufficient infrastructure and trained manpower and inadequacy in cancer registries, there are not much data available on the countrywide HPV prevalence and its type distribution in different cancers in India. Forthcoming introduction of recently developed HPV vaccines in India given a new urgency to know the prevalence and distribution of various HPV types in different organ sites for the management and monitoring of vaccination program and its impact on prevalence of other cancers. This review, summarizes studies on the prevalence of HPV infection in cancers of different organ sites in India.
临床流行病学和分子研究已经确立了人乳头瘤病毒(HPV)感染与宫颈癌之间的因果关系,以及 HPV 感染与其他几种癌症的关联。在印度,宫颈癌是女性中发病率最高的癌症,几乎所有宫颈癌病例都显示出高危型(HR)HPV 感染的流行。HPV 还在印度相当一部分口腔、食管、肛门、阴道、外阴和阴茎癌以及一小部分肺癌、喉癌和胃癌中被检测到。由于缺乏有组织的 HPV 筛查计划、基础设施不足、训练有素的人力不足以及癌症登记处不足,印度全国 HPV 流行率及其在不同癌症中的型别分布的数据并不多。最近在印度推出的 HPV 疫苗的推出,使得了解不同器官部位 HPV 各型别流行率及其分布的工作变得更加紧迫,以便对疫苗接种计划的管理和监测及其对其他癌症流行率的影响进行管理和监测。这篇综述总结了印度不同器官部位癌症中 HPV 感染流行率的研究。